Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 11 (11), 649-62

Global Epidemiology of Gout: Prevalence, Incidence and Risk Factors

Affiliations
Review

Global Epidemiology of Gout: Prevalence, Incidence and Risk Factors

Chang-Fu Kuo et al. Nat Rev Rheumatol.

Abstract

Gout is a crystal-deposition disease that results from chronic elevation of uric acid levels above the saturation point for monosodium urate (MSU) crystal formation. Initial presentation is mainly severely painful episodes of peripheral joint synovitis (acute self-limiting 'attacks') but joint damage and deformity, chronic usage-related pain and subcutaneous tophus deposition can eventually develop. The global burden of gout is substantial and seems to be increasing in many parts of the world over the past 50 years. However, methodological differences impair the comparison of gout epidemiology between countries. In this comprehensive Review, data from epidemiological studies from diverse regions of the world are synthesized to depict the geographic variation in gout prevalence and incidence. Key advances in the understanding of factors associated with increased risk of gout are also summarized. The collected data indicate that the distribution of gout is uneven across the globe, with prevalence being highest in Pacific countries. Developed countries tend to have a higher burden of gout than developing countries, and seem to have increasing prevalence and incidence of the disease. Some ethnic groups are particularly susceptible to gout, supporting the importance of genetic predisposition. Socioeconomic and dietary factors, as well as comorbidities and medications that can influence uric acid levels and/or facilitate MSU crystal formation, are also important in determining the risk of developing clinically evident gout.

Similar articles

  • New Insights Into the Epidemiology of Gout
    M Doherty. Rheumatology (Oxford) 48 Suppl 2, ii2-ii8. PMID 19447779. - Review
    Gout is a true crystal deposition disease caused by formation of monosodium urate crystals in joints and other tissues. It is a common inflammatory arthritis that has inc …
  • The Changing Epidemiology of Gout
    E Roddy et al. Nat Clin Pract Rheumatol 3 (8), 443-9. PMID 17664951. - Review
    Gout is one of the most common inflammatory arthritides, which is considered to be a true crystal deposition disorder caused by the formation of monosodium urate crystals …
  • Overview of Serum Uric Acid Treatment Targets in Gout: Why Less Than 6 mg/dL?
    G Ruoff et al. Postgrad Med 128 (7), 706-15. PMID 27558643. - Review
    Gout is a progressive, painful, debilitating form of inflammatory arthritis. It is caused by factors that elevate the concentration of serum uric acid (sUA), leading to h …
  • Epidemiology of Gout: An Update
    EU Smith et al. Best Pract Res Clin Rheumatol 24 (6), 811-27. PMID 21665128. - Review
    Gout is the most common inflammatory joint disease in men, characterised by formation of monosodium urate (MSU) crystals in the synovial fluid of joints and in other tiss …
  • Relationship Between Structural Joint Damage and Urate Deposition in Gout: A Plain Radiography and Dual-Energy CT Study
    N Dalbeth et al. Ann Rheum Dis 74 (6), 1030-6. PMID 24521739.
    MSU crystals are frequently present in joints affected by radiographic damage in gout. These findings support the concept that MSU crystals interact with articular tissue …
See all similar articles

Cited by 139 PubMed Central articles

See all "Cited by" articles

References

    1. J Clin Hypertens (Greenwich). 2012 Oct;14(10):675-9 - PubMed
    1. Asia Pac J Clin Nutr. 2011;20(2):301-8 - PubMed
    1. Curr Rheumatol Rep. 2014 Feb;16(2):400 - PubMed
    1. Va Med Q. 1996 Fall;123(4):271 - PubMed
    1. Am J Med. 1987 Mar;82(3):421-6 - PubMed

LinkOut - more resources

Feedback